Isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

Lancet. 1998 Jun 13;351(9118):1813. doi: 10.1016/S0140-6736(05)78776-6.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • AIDS-Related Opportunistic Infections / prevention & control*
  • Antitubercular Agents / therapeutic use*
  • Developing Countries
  • Drug Therapy, Combination
  • HIV-1*
  • Humans
  • Isoniazid / therapeutic use
  • Pyrazinamide / therapeutic use
  • Rifampin / therapeutic use
  • Tuberculosis / prevention & control*

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Isoniazid
  • Rifampin